Factory Mutual Insurance CO Vertex Pharmaceuticals Inc Transaction History

Factory Mutual Insurance CO

$9.5 Billion
Q3 2024

A detailed history of Factory Mutual Insurance CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Factory Mutual Insurance CO holds 29,900 shares of VRTX stock, worth $13.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

29,900

Previous 29,900 -0.0%

Holding current value

$13.5 Million

Previous $14 Million 0.78%

% of portfolio

0.15%

Previous 0.16%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$314.42 - $351.91 $4.18 Million - $4.68 Million	-13,300 Reduced 30.79%	29,900 $10.5 Million
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $24.7 Million - $31.2 Million	-139,455 Reduced 76.35%	43,200 $9.66 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $217,667 - $243,588	-1,200 Reduced 0.65%	182,655 $33.1 Million
Q2 2021 Jul 14, 2021	BUY	$187.49 - $221.1 $15.5 Million - $18.3 Million	82,555 Added 81.5%	183,855 $37.1 Million
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $21 Million - $24.4 Million	101,300 New	101,300 $21.8 Million
Q3 2019 Oct 22, 2019	SELL	$166.23 - $187.09 $14.5 Million - $16.3 Million	-87,000 Closed	0 $0
Q2 2019 Jul 16, 2019	BUY	$164.61 - $190.37 $14.3 Million - $16.6 Million	87,000 New	87,000 $16 Million
Q1 2019 Apr 09, 2019	SELL	$163.73 - $194.7 $15.3 Million - $18.2 Million	-93,300 Closed	0 $0
Q4 2018 Jan 14, 2019	SELL	$151.91 - $192.21 $6.93 Million - $8.76 Million	-45,600 Reduced 32.83%	93,300 $15.5 Million
Q3 2018 Oct 10, 2018	SELL	$167.73 - $192.74 $6.49 Million - $7.46 Million	-38,700 Reduced 21.79%	138,900 $26.8 Million
Q3 2017 Oct 11, 2017	BUY	$148.13 - $162.24 $26.3 Million - $28.8 Million	177,600	177,600 $27 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Factory Mutual Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Factory Mutual Insurance CO with notifications on news.

Account

Factory Mutual Insurance CO Vertex Pharmaceuticals Inc Transaction History